BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11159946)

  • 1. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH.
    Bruder CE; Hirvelä C; Tapia-Paez I; Fransson I; Segraves R; Hamilton G; Zhang XX; Evans DG; Wallace AJ; Baser ME; Zucman-Rossi J; Hergersberg M; Boltshauser E; Papi L; Rouleau GA; Poptodorov G; Jordanova A; Rask-Andersen H; Kluwe L; Mautner V; Sainio M; Hung G; Mathiesen T; Möller C; Pulst SM; Harder H; Heiberg A; Honda M; Niimura M; Sahlén S; Blennow E; Albertson DG; Pinkel D; Dumanski JP
    Hum Mol Genet; 2001 Feb; 10(3):271-82. PubMed ID: 11159946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
    Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
    Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
    Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
    Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of NF2 gene specific, strictly sequence defined diagnostic microarray for deletion detection.
    Mantripragada KK; Buckley PG; Jarbo C; Menzel U; Dumanski JP
    J Mol Med (Berl); 2003 Jul; 81(7):443-51. PubMed ID: 12830322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of germline NF2 gene rearrangements.
    Legoix P; Sarkissian HD; Cazes L; Giraud S; Sor F; Rouleau GA; Lenoir G; Thomas G; Zucman-Rossi J
    Genomics; 2000 Apr; 65(1):62-6. PubMed ID: 10777666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
    Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF2 gene in neurofibromatosis type 2 patients.
    Zucman-Rossi J; Legoix P; Der Sarkissian H; Cheret G; Sor F; Bernardi A; Cazes L; Giraud S; Ollagnon E; Lenoir G; Thomas G
    Hum Mol Genet; 1998 Dec; 7(13):2095-101. PubMed ID: 9817927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.
    Warren C; James LA; Ramsden RT; Wallace A; Baser ME; Varley JM; Evans DG
    J Med Genet; 2003 Nov; 40(11):802-6. PubMed ID: 14627667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH).
    Antinheimo J; Sallinen SL; Sallinen P; Haapasalo H; Helin H; Horelli-Kuitunen N; Wessman M; Sainio M; Jääskeläinen J; Carpén O
    Acta Neurochir (Wien); 2000; 142(10):1099-104; discussion 1104-5. PubMed ID: 11129530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
    Diebold R; Bartelt-Kirbach B; Evans DG; Kaufmann D; Hanemann CO
    J Mol Diagn; 2005 Feb; 7(1):97-104. PubMed ID: 15681480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular biological analysis of neurofibromatosis type 2 gene].
    Ichimura K; Yuasa Y
    Nihon Rinsho; 1993 Sep; 51(9):2462-6. PubMed ID: 8411729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma.
    Zirn B; Arning L; Bartels I; Shoukier M; Hoffjan S; Neubauer B; Hahn A
    Clin Genet; 2012 Jan; 81(1):82-7. PubMed ID: 21175598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2.
    Arai E; Tokino T; Imai T; Inazawa J; Ikeuchi T; Tonomura A; Nakamura Y
    Genes Chromosomes Cancer; 1993 Apr; 6(4):235-8. PubMed ID: 7685627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.
    Díaz de Ståhl T; Hansson CM; de Bustos C; Mantripragada KK; Piotrowski A; Benetkiewicz M; Jarbo C; Wiklund L; Mathiesen T; Nyberg G; Collins VP; Evans DG; Ichimura K; Dumanski JP
    Hum Genet; 2005 Oct; 118(1):35-44. PubMed ID: 16078050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of 16 polymorphic markers in the NF2 gene: application to hemizygosity detection.
    Legoix P; Legrand MF; Ollagnon E; Lenoir G; Thomas G; Zucman-Rossi J
    Hum Mutat; 1999; 13(4):290-3. PubMed ID: 10220142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
    Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
    Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.